HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.

Abstract
Diet-induced obesity is associated with proteinuria and glomerular disease in humans and rodents. We have shown that in mice fed a high-fat diet, increased renal expression of the transcriptional factor sterol-regulatory element binding protein-1 (SREBP-1) plays a critical role in renal lipid accumulation and increases the activity of proinflammatory cytokines and profibrotic growth factors. In the current study, we have determined a key role of the farnesoid X receptor (FXR) in modulating renal SREBP-1 activity, glomerular lesions, and proteinuria. We found that feeding a Western-style diet to DBA/2J mice results in proteinuria, podocyte loss, mesangial expansion, renal lipid accumulation, and increased expression of proinflammatory factors, oxidative stress, and profibrotic growth factors. Treatment of these mice with the highly selective and potent FXR-activating ligand 6-alpha-ethyl-chenodeoxycholic acid (INT-747) ameliorates triglyceride accumulation by modulating fatty acid synthesis and oxidation, improves proteinuria, prevents podocyte loss, mesangial expansion, accumulation of extracellular matrix proteins, and increased expression of profibrotic growth factors and fibrosis markers, and modulates inflammation and oxidative stress. Our results therefore indicate that FXR activation could represent an effective therapy for treatment of abnormal renal lipid metabolism with associated inflammation, oxidative stress, and kidney pathology in patients affected by obesity.
AuthorsXiaoxin X Wang, Tao Jiang, Yan Shen, Luciano Adorini, Mark Pruzanski, Frank J Gonzalez, Pnina Scherzer, Linda Lewis, Shinobu Miyazaki-Anzai, Moshe Levi
JournalAmerican journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 297 Issue 6 Pg. F1587-96 (Dec 2009) ISSN: 1522-1466 [Electronic] United States
PMID19776172 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Extracellular Matrix Proteins
  • Fatty Acids
  • Inflammation Mediators
  • Intercellular Signaling Peptides and Proteins
  • Receptors, Cytoplasmic and Nuclear
  • Srebf1 protein, mouse
  • Sterol Regulatory Element Binding Protein 1
  • Triglycerides
  • obeticholic acid
  • farnesoid X-activated receptor
  • Chenodeoxycholic Acid
Topics
  • Animals
  • Chenodeoxycholic Acid (analogs & derivatives, pharmacology)
  • Diet (adverse effects)
  • Extracellular Matrix Proteins (antagonists & inhibitors)
  • Fatty Acids (antagonists & inhibitors)
  • Fibrosis (etiology)
  • Glomerular Mesangium (pathology)
  • Inflammation Mediators (metabolism)
  • Intercellular Signaling Peptides and Proteins (metabolism)
  • Kidney (metabolism, pathology)
  • Kidney Glomerulus (pathology)
  • Lipid Metabolism
  • Male
  • Mice
  • Mice, Inbred DBA
  • Mice, Knockout
  • Nephritis (etiology, pathology)
  • Oxidative Stress (drug effects)
  • Podocytes (pathology)
  • Proteinuria (etiology, physiopathology)
  • Receptors, Cytoplasmic and Nuclear (drug effects, metabolism)
  • Sterol Regulatory Element Binding Protein 1 (metabolism)
  • Triglycerides (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: